Synapse - The CDK4/6 inhibitor abemaciclib in patients with recurrent meningioma and other primary CNS tumors

The CDK4/6 inhibitor abemaciclib in patients with recurrent meningioma and other primary CNS tumors Meeting Abstract

Authors:	Coffee, E.; Panageas, K.; Young, R.; Morrison, T.; Daher, A.; Grommes, C.; Gavrilovic, I. T.; Lin, A.; Miller, A.; Schaff, L.; Daras, M.; DeAngelis, L.; Diamond, E.; Piotrowski, A.; Malani, R.; Nolan, C.; Pentsova, E.; Santomasso, B.; Stone, J.; Nair, S.; Mellinghoff, I. K.; Kaley, T.
Abstract Title:	The CDK4/6 inhibitor abemaciclib in patients with recurrent meningioma and other primary CNS tumors
Meeting Title:	26th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO)
Journal Title:	Neuro-Oncology
Volume:	23
Issue:	Suppl. 6
Meeting Dates:	2021 Nov 18-21
Meeting Location:	Boston, MA
ISSN:	1522-8517
Publisher:	Oxford University Press
Date Published:	2021-11-01
Start Page:	vi72
End Page:	vi73
Language:	English
ACCESSION:	WOS:000757356200282
PROVIDER:	wos
DOI:	10.1093/neuonc/noab196.280
Notes:	Meeting Abstract: CTNI-55 -- Source: Wos